The core infrastructure of the Microbiota Therapeutics Outcomes Program is supported by a University of Toronto Department of Medicine Integrating Challenge Grant.
There are three funded studies currently involved with the MTOP.
1. Long-term Measurement of Multidisciplinary Outcomes in Patients Receiving Fecal Microbiota Transplantation (FMT) in the University of Toronto Microbiota Therapeutics Outcomes Program (MTOP)
Principal Investigators: Susy Hota, Susan M. Poutanen
Funding Agency: Department of Medicine Integrating Challenge Grant Program
Contact person: Jenita Chrysostoum, firstname.lastname@example.org / 416-340-4800 ext. 8353
2. Fecal microbiota transplant from healthy lean donors to morbidly obese individuals: effect on insulin resistance and other obesity-related parameters. A randomized controlled trial.
Principal Investigator: Dr. Johane Allard
Funding Agency: CIHR
Contact person: Monica Laura Ponta, email@example.com / 416-340-4413
3. Name of the Study: A Randomized Controlled Trial of the Safety and Efficacy of Fecal Microbiota Transplantation in a Population with Bipolar Disorder
Principal investigator: Dr. Valerie Taylor
Funding Agency: The Stanley Medical Research Institute (SMRI)
Contact person: Asem Bala, firstname.lastname@example.org / 416-351-3732 ext. 2301